KSP/QRH dimer

DRUG2 trials

Sponsors

University of Michigan, Danielle Kim Turgeon

Conditions

Barrett EsophagusCholangiocarcinoma

Phase 1

Phase 1B Study of KSP/QRH Dimer for Detection of Neoplasia in the Esophagus

TerminatedNCT03852576

University of MichiganBarrett Esophagus

Start: 2019-05-09End: 2020-11-18Updated: 2022-11-22

Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide Dimer

TerminatedNCT04304781

Danielle Kim TurgeonCholangiocarcinoma

Start: 2020-09-22End: 2021-12-17Updated: 2022-11-22